Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy
Open Access
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (4), 593-599
- https://doi.org/10.1038/mt.2008.301
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Treatment of Leber Congenital Amaurosis Due toRPE65Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- Identification and characterization of rod-derived cone viability factorNature Genetics, 2004
- Adeno-Associated Virus Type 5: Transduction Efficiency and Cell-Type Specificity in the Primate RetinaHuman Gene Therapy, 2003
- Coupling of RNAi-Mediated Target Downregulation with Gene ReplacementAntisense and Nucleic Acid Drug Development, 2003
- Sensitivity of photoreceptor-derived cell line (661W) to baculoviral p35, Z-VAD.FMK, and Fas-associated death domain.2002
- NEW EMBO MEMBER'S REVIEW: On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic interventionThe EMBO Journal, 2002
- A point mutation of the rhodopsin gene in one form of retinitis pigmentosaNature, 1990
- Autosomal dominant retinitis pigmentosa (ADRP): Localization of an ADRP gene to the long arm of chromosome 3Genomics, 1989
- Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptidesBiochemistry, 1984